China Biotech Services Holdings Limited (08037.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 18Aug 21Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−16.4x

Market Cap

HKD 614.49M

MomentumView details →

1D Return

+3.28%

YTD Return

−20.25%

RSI (14)

53.2

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−16.4x

Market Cap

HKD 614.49M

RSI (14)

53.2

MomentumView details →

1D Return

+3.28%

YTD Return

−20.25%

ProfitabilityView details →

Gross Margin

12.75%

Net Margin

−37.84%

EBITDA Margin

−66.59%

ROE (TTM)

−15.97%

ROA (TTM)

−4.24%

Asset Turnover

0.12x

GrowthView details →

Revenue YoY

+23.84%

EPS YoY

+80.31%

FCF YoY

—

Revenue CAGR 3Y

−65.89%

EPS CAGR 3Y

+64.75%

EBITDA YoY

+35.17%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

2.13x

Current Ratio

0.99x

Quick Ratio

0.63x

Div Yield

—

Div Rate

—

Div Growth 1Y

−97.47%

Financials snapshotView financials →

Revenue (TTM)

91.29M

Net Income (TTM)

−34.55M

Op. CF (TTM)

—

Latest newsMore news →

No recent news for 08037.HK.

Similar companies

Fulgent Genetics, Inc.FLGT Prenetics Global LimitedPRE Aclaris Therapeutics, Inc.ACRS Castle Biosciences, Inc.CSTL OPKO Health, Inc.OPK Myriad Genetics, Inc.MYGN Find similar companies →

Latest newsMore news →

No recent news for 08037.HK.